| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1404 | 2019 |
| Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised … CO Morrissey, SCA Chen, TC Sorrell, S Milliken, PG Bardy, KF Bradstock, ... The Lancet Infectious Diseases 13 (6), 519-528, 2013 | 242 | 2013 |
| Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality M Slavin, S Van Hal, TC Sorrell, A Lee, DJ Marriott, K Daveson, ... Clinical Microbiology and Infection 21 (5), 490. e1-490. e10, 2015 | 190 | 2015 |
| Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death MA Slavin, TC Sorrell, D Marriott, KA Thursky, Q Nguyen, DH Ellis, ... Journal of antimicrobial chemotherapy 65 (5), 1042-1051, 2010 | 179 | 2010 |
| Changing epidemiology of candidaemia in Australia B Chapman, M Slavin, D Marriott, C Halliday, S Kidd, I Arthur, N Bak, ... Journal of Antimicrobial Chemotherapy 72 (4), 1103-1108, 2017 | 173 | 2017 |
| The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ … S Husain, A Sole, BD Alexander, S Aslam, R Avery, C Benden, EM Billaud, ... The Journal of Heart and Lung Transplantation 35 (3), 261-282, 2016 | 172 | 2016 |
| Antifungal prophylaxis in lung transplantation—a world-wide survey CF Neoh, GI Snell, T Kotsimbos, B Levvey, CO Morrissey, MA Slavin, ... American Journal of Transplantation 11 (2), 361-366, 2011 | 160 | 2011 |
| Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology OA Cornely, M Hoenigl, C Lass‐Flörl, SCA Chen, DP Kontoyiannis, ... Mycoses 62 (9), 716-729, 2019 | 141 | 2019 |
| Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic … SC Heng, O Morrissey, SCA Chen, K Thursky, RL Manser, RL Nation, ... Critical reviews in microbiology 41 (1), 124-134, 2015 | 141 | 2015 |
| Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia AR Tramontana, B George, AC Hurt, JS Doyle, K Langan, AB Reid, ... Emerging infectious diseases 16 (7), 1068, 2010 | 139 | 2010 |
| Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014 S Fleming, CK Yannakou, GM Haeusler, J Clark, A Grigg, CH Heath, ... Internal medicine journal 44 (12b), 1283-1297, 2014 | 136 | 2014 |
| Mucormycosis in Australia: contemporary epidemiology and outcomes KJ Kennedy, K Daveson, MA Slavin, SJ Van Hal, TC Sorrell, A Lee, ... Clinical Microbiology and Infection 22 (9), 775-781, 2016 | 100 | 2016 |
| Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period. PA Macesic N, Morrissey O, Cheng A, Spencer A Transpl Infect Dis 16, 887-896, 2014 | 86 | 2014 |
| Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach MR Ananda-Rajah, A Cheng, CO Morrissey, T Spelman, M Dooley, ... Antimicrobial agents and chemotherapy 55 (5), 1953-1960, 2011 | 86 | 2011 |
| Identifying cytomegalovirus complications using the quantiferon-CMV assay after allogeneic hematopoietic stem cell transplantation MK Yong, PU Cameron, M Slavin, CO Morrissey, K Bergin, A Spencer, ... The Journal of infectious diseases 215 (11), 1684-1694, 2017 | 78 | 2017 |
| Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter … SM Yong MK, Ananda-Rajah M, Cameron PU, Morrissey CO, Spencer A, Ritchie D ... Biol Blood Marrow Transplant 23, 1962-1967, 2017 | 78* | 2017 |
| Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections MA Slavin, J Szer, AP Grigg, AW Roberts, JF Seymour, J Sasadeusz, ... Internal medicine journal 34 (4), 192-200, 2004 | 76 | 2004 |
| Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia. GN Cornely OA, Leguay T, Maertens J, Vehreschild MJGT, Anagostopoulos A ... J Antimicrob Chemother 72, 2359-2367, 2017 | 74 | 2017 |
| Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021 AP Douglas, OC Smibert, A Bajel, CL Halliday, O Lavee, B McMullan, ... Internal Medicine Journal 51, 143-176, 2021 | 68 | 2021 |
| Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial GR Thompson, A Soriano, OA Cornely, BJ Kullberg, M Kollef, J Vazquez, ... The Lancet 401 (10370), 49-59, 2023 | 66 | 2023 |
